PeptiSyntPRECISION IN SEQUENCE.
Ships unlabeled

GHK-Cu + KPV Blend

Research Peptide | Lyophilized Powder | Batch Tested

Size
$156.00
$0.26/mg
In Stock
1

For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.

Product Overview

GHK-Cu + KPV is a two-component research blend supplied in boxes of 10 vials. CK60 contains 50 mg GHK-Cu and 10 mg KPV per vial, totaling 60 mg. CK100 contains 100 mg GHK-Cu and 10 mg KPV per vial, totaling 110 mg; CK100 is the SKU name, not its combined component mass.

No published certificates yet.

SKU & packaging

SKUPer vialVials per packPack price
CK6060 mg10$156.00
CK100110 mg10$182.00

Nominal sizes describe the product label; measured results are listed in each batch report. Published reports do not confirm the batch allocated to a future order.

Product & documentation questions

How do I read the size and pack quantity?

The per-vial size and number of vials per pack are listed separately in the table. The displayed price is for one pack. A blend’s stated size can describe combined ingredients; check its product label and report for individual components.

How do I find the matching COA?

Match the product, SKU and batch number with the published report. Open the batch page to read the actual results, original report and laboratory verification link. Ask support to confirm the allocated batch if it is not on your order.

Does a purity result mean every test passed?

No. Identity, purity, fill and endotoxin are separate measurements. Read each reported result and unit. An absent result is not a pass, and a less-than result is not zero.

Research Information

This blend pairs a copper-complexed tripeptide studied in extracellular-matrix models with KPV, a tripeptide investigated in PepT1-mediated uptake and inflammatory-signaling models. CK60 and CK100 differ in GHK-Cu content while retaining 10 mg KPV per vial. Ingredient research does not establish equivalent behavior across the two formulations.

GHK-Cu + KPV Blend Research & Studies

CK60 and CK100 composition

CK60 provides GHK-Cu 50 mg plus KPV 10 mg per vial, totaling 60 mg. CK100 provides GHK-Cu 100 mg plus KPV 10 mg per vial, totaling 110 mg. Both presentations contain 10 vials per box. CK100 is a catalog identifier and should not be interpreted as 100 mg total content.

GHK-Cu research context

GHK-Cu is glycyl-L-histidyl-L-lysine complexed with copper. Primary cell-culture research examined collagen synthesis and production of specific glycosaminoglycans in fibroblasts. These studies support matrix-biology research topics without establishing the behavior of the combined product.

KPV research context

Lys-Pro-Val, abbreviated KPV, has been investigated in intestinal epithelial and immune-cell systems for PepT1-mediated uptake and inflammatory responses. Mouse colitis studies provide additional preclinical context. These findings describe experimental models, not a demonstrated treatment application for this blend.

Comparing the two formulations

The labeled GHK-Cu:KPV mass ratio is 5:1 in CK60 and 10:1 in CK100. These are mass ratios, not molar ratios. Comparative assays should account for each component's concentration; neither the higher GHK-Cu content nor a shared ingredient list establishes a stronger biological effect.

Evidence for the combination

The references concern individual ingredients. They do not test these exact CK60 or CK100 formulations or establish a synergistic effect. Ingredient controls and appropriate assay readouts can help distinguish component-specific responses from those of the mixture.

Frequently Asked Questions

Does CK100 contain 100 mg total per vial?

No. CK100 contains 100 mg GHK-Cu plus 10 mg KPV per vial, totaling 110 mg of labeled components.

What changes between CK60 and CK100?

GHK-Cu increases from 50 mg to 100 mg per vial. KPV remains 10 mg per vial, and both SKUs are supplied as 10 vials per box.

Does this blend contain BPC-157?

No. These two SKUs contain GHK-Cu and KPV. GKP70 is a separate three-component product that also contains BPC-157.

What do the cited studies establish?

They document ingredient-level experimental findings. They do not demonstrate synergy or clinical effectiveness of the blend, which is offered for laboratory research only.

Learn more

Read research overviews, COA verification guides, and reconstitution notes in our Knowledge Hub.

Explore Other High-Purity Peptides